Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Cash & Current Investments (2017 - 2026)

Updated

Summit Therapeutics' Cash & Current Investments was $690.68 million in Q2 2026, up 131.9% from $297.87 million a year earlier and up 15.4% from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Summit Therapeutics came in at $713.45 million, up 73.0% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 60.8% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $412.35 million in FY2024 (+121.4%), $186.24 million in FY2023 (-46.6%), $348.61 million in FY2022 (+385.6%) and $71.79 million in FY2021 (+8.1%).
  • Quarterly Cash & Current Investments has moved between $71.79 million (Q4 2021) and $713.45 million (Q4 2025) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 76.0% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2022 (growth of 385.6%); the worst was Q3 2025 (a decline of 51.0%).
  • Per Business Quant data, SMMT's Cash & Current Investments in the three quarters before Q2 2026 was $598.73 million (Q1 2026), $713.45 million (Q4 2025) and $238.55 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 20.76 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.57 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 7.14 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.92 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 4.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 3.18 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 11.70 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.85 Bn
10 Summit Therapeutics 12.28 Bn 10.04 Bn - 690.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 690.68 Mn
Mar 31, 2026 598.73 Mn
Dec 31, 2025 713.45 Mn
Sep 30, 2025 238.55 Mn
Jun 30, 2025 297.87 Mn
Mar 31, 2025 361.32 Mn
Dec 31, 2024 412.35 Mn
Sep 30, 2024 486.90 Mn
Jun 30, 2024 325.47 Mn
Mar 31, 2024 156.68 Mn
Dec 31, 2023 186.24 Mn
Sep 30, 2023 198.95 Mn
Jun 30, 2023 215.01 Mn
Mar 31, 2023 241.93 Mn
Dec 31, 2022 348.61 Mn
Sep 30, 2022 121.97 Mn
Dec 31, 2021 71.79 Mn
Jun 30, 2021 103.40 Mn
Mar 31, 2021 102.20 Mn
Dec 31, 2020 66.42 Mn
API Access

Summit Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SMMT&period=max&api_key=YOUR_API_KEY